🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to determine the progression-free survival rate i...
Status
Completed
Location
University of Michigan Comprehensive Cancer Center
Start Date
2007-09
Trial ID
NCT00616109
Treatments Being Tested
The purpose of this study is to find out what effects, good and/or bad, sun...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2007-10
Trial ID
NCT00589784
Treatments Being Tested
This is an open label, multi-center, Phase 1/2 study of BBI503 administered...
Status
Completed
Location
Parkview Research Center
Start Date
2015-09
Trial ID
NCT02483247
Treatments Being Tested
Sunitinib shows anti-tumor activity in a variety of human non-small cell lu...
Status
Unknown
Location
Section of Hematology, Department of Medicine,Taipei Medical University Hospital
Start Date
2009-01
Trial ID
NCT01019798
Treatments Being Tested
Phase I;To investigate the clinically recommended dose of Sunitinib malate ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-01
Trial ID
NCT00457743
Treatments Being Tested
Observational, retrospective, multicentre study in spanish patients with me...
Status
Completed
Location
Hospital Duran i Reynals
Start Date
2019-12-17
Trial ID
NCT03916458
The purpose of this study is to determine whether Sunitinib and Docetaxel i...
Status
Completed
Location
Samsung Medical Center
Start Date
2008-11
Trial ID
NCT01238055
Treatments Being Tested
The purpose of this study is to find out if a new drug, called IDRX-42 (als...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-12-03
Trial ID
NCT07218926
The purpose of this study is to evaluate the safety and efficacy of single ...
Status
Completed
Location
Retinal Consultants of Arizona
Start Date
2017-08-29
Trial ID
NCT03249740
Treatments Being Tested
The purpose of this research study is to determine the safety and tolerabil...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2014-07
Trial ID
NCT02164240
Treatments Being Tested